[Federal Register Volume 66, Number 18 (Friday, January 26, 2001)]
[Notices]
[Pages 7915-7916]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-2326]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Notice of Meeting: Secretary's Advisory Committee on Generic 
Testing

    Pursuant to Public Law 92-463, notice is hereby given of the 
seventh meeting of the Secretary's Advisory Committee on Genetic 
Testing (SACGT), U.S. Public Health Service. The meeting will be held 
from 9 a.m. to 3:15 p.m. on February 15, 2001 and 10:15 a.m. to 4:30 
p.m. on February 16, 2001 at the National Institutes of Health, 
Building 31, C Wing, Conference Room 10, 9000 Rockville Pike, Bethesda, 
MD 20892. The meeting will be open to the public with attendance 
limited to space available.
    The Committee will discuss a number of topics, including a proposed 
classification methodology for genetic tests; a draft genetic test 
information template for health professionals; and a draft white paper 
on genetics education for health professionals. Breakout sessions are 
scheduled for SACGT's working groups to meet and discuss ongoing and 
future projects. The Committee will be updated on the working groups' 
activities and progress during the full Committee meeting. The 
Committee will also hear an update on the activities of the Food and 
Drug Administration. There will be a limited period of time provided 
for public comment and interested individuals

[[Page 7916]]

should notify the contact person listed below.
    Under authority of 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established SACGT to advise and make recommendations to the Secretary 
through the Assistant Secretary for Health on all aspects of the 
development and use of genetic tests. The SACGT is directed to (1) 
recommend policies and procedures for the safe and effective 
incorporation of genetic technologies into health care; (2) assess the 
effectiveness of existing and future measures for oversight of genetic 
tests; and (3) identify research needs related to the Committee's 
purview.
    The draft meeting agenda and other information about SACGT will be 
available at the following web site: http://www4.od.nih.gov/oba/sacgt.htm. Individuals who wish to provide public comments or who plan 
to attend the meeting and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
notify the SACGT Executive Secretary, Ms. Sarah Carr, by telephone at 
301-496-9838 or E-mail at [email protected]. The SACGT office is located 
at 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892.

    Dated: January 11, 2001.
Sarah Carr,
Executive Secretary, SACGT.
[FR Doc. 01-2326 Filed 1-25-01; 8:45 am]
BILLING CODE 4140-01-M